Parathyroid hormone-related protein (PTHrP) is a
proteinaceous
hormone and a member of the
parathyroid hormone family secreted by
mesenchymal stem cells. It is occasionally secreted by
cancer cells (for example,
breast cancer, certain types of
lung cancer including
squamous-cell lung carcinoma
Squamous-cell carcinoma (SCC) of the lung is a histologic type of non-small-cell lung carcinoma (NSCLC). It is the second most prevalent type of lung cancer after lung adenocarcinoma and it originates in the bronchi. Its tumor cells are character ...
). However, it also has normal functions in
bone,
teeth,
vascular tissues and other tissues.
Function
PTHrP acts as an
endocrine
The endocrine system is a messenger system comprising feedback loops of the hormones released by internal glands of an organism directly into the circulatory system, regulating distant target organs. In vertebrates, the hypothalamus is the neu ...
,
autocrine,
paracrine, and
intracrine hormone. It regulates
endochondral bone development by maintaining the endochondral growth plate at a constant width. It also regulates
epithelial–mesenchymal interactions during the formation of the mammary glands. PTHrP plays a major role in regulating calcium homeostasis in vertebrates, including sea bream, chick, and mammals.
In 2005, Australian pathologist and researcher
Thomas John Martin
Thomas may refer to:
People
* List of people with given name Thomas
* Thomas (name)
* Thomas (surname)
* Saint Thomas (disambiguation)
* Thomas Aquinas (1225–1274) Italian Dominican friar, philosopher, and Doctor of the Church
* Thomas the Ap ...
found that PTHrP produced by
osteoblast
Osteoblasts (from the Greek language, Greek combining forms for "bone", ὀστέο-, ''osteo-'' and βλαστάνω, ''blastanō'' "germinate") are cell (biology), cells with a single Cell nucleus, nucleus that synthesize bone. However, in the p ...
s is a physiological regulator of
bone formation.
Martin and Miao ''et al.'' demonstrated that osteoblast-specific
ablation of PTHrP in mice results in osteoporosis and impaired bone formation both in vivo and ex vivo, which reiterates the
phenotype of mice with
haploinsufficiency of PTHrP. By these findings, they demonstrated that PTHrP plays a central role in physiological regulation of bone formation by promoting recruitment and survival of osteoblasts. It may also play a role in physiological regulation of
bone resorption by enhancing
osteoclast formation.
Tooth eruption
PTHrP is critical in intraosseous phase of tooth eruption where it acts as a signalling molecule to stimulate local bone resorption.
Without PTHrP, the bony crypt surrounding the tooth follicle will not resorb, and therefore the tooth will not erupt. In the context of tooth eruption, PTHrP is secreted by the cells of the reduced enamel epithelium.
Mammary glands
It aids in normal
mammary gland development.
It is necessary for maintenance of the
mammary bud cells. Loss of PTHrP or its receptor causes the mammary bud cells to change back into
epidermal cells. In
lactation, it may regulate the mobilization and transfer of
calcium to the milk in conjunction with the
calcium sensing receptors, as well as
placental transfer of calcium.
Humoral hypercalcemia of malignancy
PTHrP is related in function to parathyroid hormone(PTH). When a
tumor secretes PTHrP, this can lead to
hypercalcemia
Hypercalcemia, also spelled hypercalcaemia, is a high calcium (Ca2+) level in the blood serum. The normal range is 2.1–2.6 mmol/L (8.8–10.7 mg/dL, 4.3–5.2 mEq/L), with levels greater than 2.6 mmol/L defined as hypercalcemi ...
.
As this is sometimes the first sign of the
malignancy, hypercalcemia caused by PTHrP is considered a
paraneoplastic phenomenon
A paraneoplastic syndrome is a syndrome (a set of signs and symptoms) that is the consequence of a tumor in the body (usually a cancerous one), specifically due to the production of chemical signaling molecules (such as hormones or cytokines) by ...
. PTHrP is responsible for most cases of humoral hypercalcemia of malignancy.
PTHrP shares the same
N-terminal
The N-terminus (also known as the amino-terminus, NH2-terminus, N-terminal end or amine-terminus) is the start of a protein or polypeptide, referring to the free amine group (-NH2) located at the end of a polypeptide. Within a peptide, the ami ...
end as parathyroid hormone and therefore it can bind to the same receptor, the Type I PTH receptor (
PTHR1). PTHrP can simulate most of the actions of PTH including increases in bone resorption and distal tubular calcium reabsorption, and inhibition of proximal tubular phosphate transport. PTHrP lacks the normal feedback inhibition as PTH.
However, PTHrP has a less sustained action than PTH on PTHR1 activation, which may explain at least in part its reduced ability to stimulate 1,25-dihydroxyvitamin D (1,25(OH)
2 vitamin D) production and indirectly intestinal calcium absorption through an action to increase circulating levels of 1,25(OH)
2 vitamin D.
Genetics
Four
alternatively spliced transcript variants encoding two distinct
isoforms have been observed. There is also evidence for alternative translation initiation from non-AUG (CUG and GUG) start sites, in-frame and downstream of the initiator AUG codon, to give rise to nuclear forms of this hormone.
Discovery
The protein was first isolated in 1987 by Thomas J. Martin's team at the
University of Melbourne. Miao ''et al''. showed that disruption of the ''PTHrP'' gene in mice caused a lethal phenotype and distinct bone abnormalities, suggesting that PTHrP has a physiological function.
Interactions
Parathyroid hormone-related protein has been shown to
interact with
KPNB1 and
Arrestin beta 1.
See also
* Analogs used as pharmaceutical drugs
**
Teriparatide
**
Abaloparatide
Abaloparatide, sold under the brand name Tymlos among others, is a parathyroid hormone-related protein (PTHrP) analog medication used to treat osteoporosis. It is an anabolic (i.e., bone growing) agent.
In 2017, it was approved to treat postmeno ...
References
Further reading
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
{{Intercellular signaling peptides and proteins
Oncology
Parathyroid hormone receptor agonists